UroGen Pharma Ltd. (URGN) Form 10-K Annual Reports
UroGen Pharma Ltd. (URGN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: URGN
CIK: 1668243
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerMichael Bey
Audit LocationFlorham Park, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-09 | 2026-10-08 | FORM 4 | 0001437749-26-032421 | View SEC Doc Filr Page |
| 144 | 2026-10-09 | — | 144 Filing | 0001976408-26-000887 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-07 | FORM 4 | 0001437749-26-029965 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-07 | FORM 4 | 0001437749-26-029963 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001976408-26-000811 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001976408-26-000810 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-26 | FORM 4 | 0001437749-26-029175 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | FORM 4 | 0001437749-26-028840 | View SEC Doc Filr Page |
| 144 | 2026-08-20 | — | 144 Filing | 0001000275-26-000100 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-18 | FORM 8-K | 0001437749-26-028590 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000947263-26-000072 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | FORM 10-Q | 0001437749-26-025794 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | FORM 8-K | 0001437749-26-025793 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-09 | FORM 4 | 0001437749-26-023290 | View SEC Doc Filr Page |
| 144 | 2026-07-09 | — | 144 Filing | 0001000275-26-000093 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | FORM 4 | 0001437749-26-021523 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | FORM 4 | 0001437749-26-021519 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | FORM 4 | 0001437749-26-021517 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | FORM 4 | 0001437749-26-021515 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | FORM 4 | 0001437749-26-021513 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | FORM 4 | 0001437749-26-021511 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | FORM 4 | 0001437749-26-021509 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-22 | FORM 8-K | 0001437749-26-021442 | View SEC Doc Filr Page |
| 144 | 2026-06-22 | — | 144 Filing | 0001000275-26-000079 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-08 | FORM 4 | 0001437749-26-019964 | View SEC Doc Filr Page |